{"schema_version":"1","generated_at":"2026-11-05T07:13:28.679Z","data_as_of":null,"url":"https://www.findmykol.com/kol/michelle-rheault","json_url":"https://www.findmykol.com/kol/michelle-rheault/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"michelle-rheault","name":"Michelle Rheault","credential":"MD","specialty":"Pediatric Nephrology","specialty_raw":"Pediatric Nephrology","therapeutic_area":"Nephrology","therapeutic_areas":["Nephrology"],"institution":"University of Minnesota","institution_url":"https://www.findmykol.com/institution/university-of-minnesota","city":"Minneapolis","state":"MN","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1013053982","orcid":"0000-0003-2494-3970","openalex":"A5014297070"},"summary":"Michelle Rheault is a Nephrology physician affiliated with University of Minnesota. OpenAlex indexes 171 publications with 4,910 citations (h-index 37); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Nephrology"]},"scholarship":{"works_count":171,"cited_by_count":4910,"h_index":37,"latest_activity_year":2025,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT03763643","title":"PRI-VENT FSGS: Preemptive Rituximab to Prevent Recurrent Focal Segmental Glomerulosclerosis Post-Transplant","phase":"EARLY_PHASE1","status":"COMPLETED","role":"Overall official","sponsor":"University of Minnesota","source_url":"https://clinicaltrials.gov/study/NCT03763643","trial_url":"https://www.findmykol.com/trial/NCT03763643"}],"source":"trials"},"payments":{"company_count":4,"program_years":{"first":2021,"last":null},"rows_total":22,"shown":3,"withheld":19,"rows":[{"payer":"Travere","program_year":2025,"amount_usd":120435.72,"payment_count":8,"source_url":"https://openpaymentsdata.cms.gov/search?query=1013053982"},{"payer":"Novartis","program_year":2025,"amount_usd":68423.84,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1013053982"},{"payer":"Aurinia","program_year":2025,"amount_usd":33420,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1013053982"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1013053982","source":"payments"},"prescribing":{"data_year":2022,"areas_total":2,"areas_shown":2,"areas":[{"area":"Cancer & immunology","share_pct":50,"classes_total":1,"classes":[{"class":"Calcineurin inhibitor","setting":"prescribed","share_pct":50,"drugs":[{"name":"Cyclosporine Modified","share_pct":100}],"max_beneficiaries":null}]},{"area":"Anti-infectives","share_pct":50,"classes_total":1,"classes":[{"class":"Short-acting sulfonamides","setting":"prescribed","share_pct":50,"drugs":[{"name":"Sulfamethoxazole-Trimethoprim","share_pct":100}],"max_beneficiaries":null}]}],"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Diagnosis, management and treatment of the Alport syndrome – 2024 guideline on behalf of ERKNet, ERA and ESPN","year":2024,"journal":"Nephrology Dialysis Transplantation","source_url":"https://doi.org/10.1093/ndt/gfae265","status":"verified"},{"title":"Rationale and design of the Nephrotic Syndrome Study Network (NEPTUNE) Match in glomerular diseases: designing the right trial for the right patient, today","year":2024,"journal":"Kidney International","source_url":"https://doi.org/10.1016/j.kint.2023.11.018","status":"verified"},{"title":"Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial","year":2023,"journal":"The Lancet","source_url":"https://doi.org/10.1016/s0140-6736(23)02302-4","status":"verified"},{"title":"Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial","year":2023,"journal":"The Lancet","source_url":"https://doi.org/10.1016/s0140-6736(23)00569-x","status":"verified"},{"title":"Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy","year":2023,"journal":"Nature Genetics","source_url":"https://doi.org/10.1038/s41588-023-01422-x","status":"verified"}],"source":"works"},"contact":{"address_1":"2512 S 7TH ST","address_2":"PEDIATRIC SPECIALTY CARE","city":"Minneapolis","state":"MN","zip":"554541404","phone":"612-365-6777","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1013053982","source":"identity"},"similar":[{"name":"Jay Cohn","slug":"jay-cohn","institution":"University of Minnesota","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/jay-cohn","json_url":"https://www.findmykol.com/kol/jay-cohn/profile.json"},{"name":"Douglas Yee","slug":"douglas-yee","institution":"University of Minnesota","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/douglas-yee","json_url":"https://www.findmykol.com/kol/douglas-yee/profile.json"},{"name":"David Benditt","slug":"david-benditt","institution":"University of Minnesota","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/david-benditt","json_url":"https://www.findmykol.com/kol/david-benditt/profile.json"},{"name":"Stuart Grossman","slug":"stuart-grossman","institution":"University of Minnesota","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/stuart-grossman","json_url":"https://www.findmykol.com/kol/stuart-grossman/profile.json"},{"name":"Andrew Levey","slug":"andrew-levey","institution":"Tufts Medical Center","specialty":"Nephrology","url":"https://www.findmykol.com/kol/andrew-levey","json_url":"https://www.findmykol.com/kol/andrew-levey/profile.json"},{"name":"Laura Svetkey","slug":"laura-svetkey","institution":"Duke University","specialty":"Nephrology","url":"https://www.findmykol.com/kol/laura-svetkey","json_url":"https://www.findmykol.com/kol/laura-svetkey/profile.json"},{"name":"Prasad Devarajan","slug":"prasad-devarajan","institution":"Cincinnati Children's Hospital Medical Center","specialty":"Pediatric Nephrology","url":"https://www.findmykol.com/kol/prasad-devarajan","json_url":"https://www.findmykol.com/kol/prasad-devarajan/profile.json"},{"name":"Rajesh V. Thakker","slug":"rajesh-thakker","institution":"Queen Mary University of London","url":"https://www.findmykol.com/kol/rajesh-thakker","json_url":"https://www.findmykol.com/kol/rajesh-thakker/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":19,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2013-02-20","collected_at":"2026-11-04T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2022}},"methodology_url":"https://www.findmykol.com/about#methodology"}